Provided by Tiger Trade Technology Pte. Ltd.

Agios Pharmaceuticals

27.96
-0.1100-0.39%
Post-market: 27.990.0300+0.11%19:53 EST
Volume:650.64K
Turnover:18.38M
Market Cap:1.63B
PE:-4.02
High:28.97
Open:28.71
Low:27.76
Close:28.07
52wk High:46.00
52wk Low:22.24
Shares:58.31M
Float Shares:51.35M
Volume Ratio:0.72
T/O Rate:1.27%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.9625
EPS(LYR):11.64
ROE:-30.20%
ROA:-19.94%
PB:1.37
PE(LYR):2.40

Loading ...

Agios Pharmaceuticals (AGIO) Valuation Check As Shares Trade Near Recent Levels And PYRUKYND Prospects Evolve

Simply Wall St.
·
Feb 14

RBC Capital Sticks to Their Hold Rating for Agios Pharma (AGIO)

TIPRANKS
·
Feb 14

Truist Financial Keeps Their Buy Rating on Agios Pharma (AGIO)

TIPRANKS
·
Feb 13

Agios Pharmaceuticals Inc : Leerink Partners Raises Target Price to $47.00 From $39.00

THOMSON REUTERS
·
Feb 13

U.S. RESEARCH ROUNDUP-Applied Materials, Humana, Waste Connections

Reuters
·
Feb 13

Regulatory Delays Threaten Agios Pharmaceuticals’ Drug Pipeline, Costs and Revenue Outlook

TIPRANKS
·
Feb 13

Agios Pharmaceuticals Signals Confident Path After Afesmi Win

TIPRANKS
·
Feb 13

Agios Pharmaceuticals Files for Mixed Shelf Offering; Size Not Disclosed - Filing

THOMSON REUTERS
·
Feb 13

Agios Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Feb 13

Agios Pharmaceuticals: Early Aqvesme Traction and REMS-Driven Uptake Support Robust Mitapivat Growth and Buy Rating

TIPRANKS
·
Feb 13

Agios reports FY 2025 net income loss of USD 412.8 million and PYRUKYND net revenues of USD 54 million, up 48 percent

Reuters
·
Feb 12

Agios Pharmaceuticals Q4 Revenue Rises

MT Newswires Live
·
Feb 12

Agios 2025 product revenue beats analyst estimates

Reuters
·
Feb 12

Agios Pharmaceuticals Q4 EPS $(1.86) Beats $(1.94) Estimate, Sales $19.967M Beat $12.014M Estimate

Benzinga
·
Feb 12

BRIEF-Agios Pharmaceuticals FY Product Revenue USD 54.028 Million Vs. IBES Estimate USD 45.7 Million

Reuters
·
Feb 12

Calendar of U.S. Earnings Expected in the Week Ahead

Dow Jones
·
Feb 11

Agios Pharmaceuticals (AGIO) Valuation Check After Extended Share Price Weakness

Simply Wall St.
·
Feb 06

Earning Preview: Agios Pharmaceuticals revenue is expected to increase by 28.81%, and institutional views are cautiously optimistic

Earnings Agent
·
Feb 05

Agios Pharmaceuticals Inc. to Report Financial Results and Business Highlights

Reuters
·
Jan 26

Is Agios Pharmaceuticals (AGIO) Pricing Reflect Its Recent Rebound And Long Term Track Record

Simply Wall St.
·
Jan 23